Study summary

Cenobamate made about half of patients seizure-free at the highest dose

Cenobamate trial in East Asia · 519 people, phase 3 · Published February 2026, Epilepsia

52.4%seizure-free during maintenance with 400 mg, vs 2.6% with placebo

What was tested

Cenobamate at three doses or placebo added to existing medicines in adults with uncontrolled focal seizures, in China, Japan and South Korea.

What they found

What it means

Confirms cenobamate as one of the most effective add-on medicines for focal epilepsy.

Epilepsia, via PubMed ↗ Trial record NCT04557085 ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.